Three female patients with myasthenia gravis treated with CAR-T cell therapy in Magdeburg; years symptom-free off medications
Three female patients with myasthenia gravis treated with CAR-T cell therapy in Magdeburg; years symptom-free off medications Medical Faculty/University Hospital Magdeburg - Cell Therapy Shows Lasting Effects in Severe Neuromuscular Autoimmune Disease Cell Therapy Shows Lasting Effects in Severe Neuromuscular Autoimmune Disease New Long-Term Data: Three female patients with the rare muscle disorder myasthenia gravis remain symptom-free years after CAR-T cell therapy and require no medication On May 30, 2023, a medical milestone was achieved at Magdeburg University Hospital: That was when, for the first time worldwide, a patient with severe, treatment-resistant myasthenia gravis was successfully treated with a B-cell-targeted CAR-T cell therapy—a procedure that originated in cancer medicine. Three years later, an interdisciplinary team has now published the long-term results for three patients in the renowned journal Cell Reports Medicine— two of whom were treated in Magdeburg. ...